Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor

Immunity. 1995 Dec;3(6):811-21. doi: 10.1016/1074-7613(95)90070-5.

Abstract

Herpesvirus Saimiri gene 13 (HVS13) exhibits 57% identity with the predicted sequence of a T cell-derived molecule termed CTLA8. Recombinant HVS13 and CTLA8 stimulate transcriptional factor NF-kappa B activity and interleukin-6 (IL-6) secretion in fibroblasts, and costimulate T cell proliferation. An HVS13.Fc fusion protein was used to isolate a cDNA encoding a novel receptor that also binds CTLA8. This receptor is unrelated to previously identified cytokine receptor families. A recombinant soluble receptor inhibited T cell proliferation and IL-2 production induced by PHA, concanavalin A (conA), and anti-TCR MAb. These results define CTLA8 and HVS13 as novel cytokines that bind to a novel cytokine receptor. We propose to call these molecules IL-17, vIL-17, and IL-17R, respectively.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antigens, Viral / immunology
  • Antigens, Viral / isolation & purification
  • Antigens, Viral / pharmacology
  • Base Sequence
  • Cell Division / drug effects
  • Cell Line
  • Cloning, Molecular
  • Herpesvirus 2, Saimiriine / genetics
  • Herpesvirus 2, Saimiriine / immunology*
  • Interleukin-17
  • Interleukins / immunology
  • Interleukins / isolation & purification*
  • Interleukins / pharmacology
  • Mice
  • Molecular Sequence Data
  • Receptors, Cytokine / immunology
  • Receptors, Cytokine / isolation & purification*
  • Receptors, Immunologic / immunology
  • Receptors, Immunologic / isolation & purification*
  • Recombinant Fusion Proteins / immunology
  • T-Lymphocytes / immunology*

Substances

  • Antigens, Viral
  • Interleukin-17
  • Interleukins
  • Receptors, Cytokine
  • Receptors, Immunologic
  • Recombinant Fusion Proteins

Associated data

  • GENBANK/U31993